Endomag is the British company that believes everyone deserves a better standard of cancer care. As the global leader in seed localisation, many of the world’s leading physicians and hospitals use our technologies to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. Using our Sentimag® probe, physicians can perform sentinel node biopsies with our lymphatic tracer (Magtrace®) and tissue localisation procedures with our breast tumour marker (Magseed®). Already, we’ve helped 75,000 women around the world access more precise and less invasive breast cancer care.